1.Design of the psychology tester based on ZigBee technology.
Chinese Journal of Medical Instrumentation 2012;36(5):350-353
OBJECTIVETo design a psychological state tester based on ZigBee wireless technology.
METHODSThrough analog circuit preprocessing, the heartbeat collected by the pulse sensor will be transformed into digital signal from analog signal, and then can be processed and displayed after transported to the personal computer through the Zigbee wireless communicate units. The data will be retrieval and playback for the measurement of psychology.
RESULTSThe experiments show that the device is able to acquire the pulse wave of the human body in real-time, at the same time, through the ZigBee wireless network, it can accomplish real-time, secure and reliable communications, and it also can be used in the research of testing the mental state of the individual.
CONCLUSIONThrough the application of the ZigBee communicate technology; the psychology tester can collect the pulse signal to reflect the individual's mental state in different conditions. So it will be applicable to a wide range of psychology measurement and other areas.
Computer Communication Networks ; instrumentation ; Equipment Design ; Heart Rate ; Humans ; Psychological Tests ; Psychology, Clinical ; instrumentation ; Signal Processing, Computer-Assisted ; instrumentation ; Wireless Technology
2.Effect of contrast media on renal function in patients with cerebrovascular disease complicated by diabetes mellitus after receiving interventional treatment
Zaigang LÜ ; Linna WANG ; Xiaohui CHEN ; Ligong ZHANG ; Mengfei ZHONG ; Haiting LI ; Zhijie YANG ; Min LI ; Tianping TANG ; Zongen GAO
Journal of Interventional Radiology 2018;27(3):277-280
Objective To evaluate the effect of contrast medium on the renal function in patients with cerebrovascular disease accompanied by diabetes mellitus after receiving neuro - interventional therapy. Methods The clinical data of a total of 108 patients with cerebrovascular disease complicated by diabetes mellitus type 2, who were treated with neuro - interventional therapy during the period from March 2013 to March 2016, were retrospectively analyzed. The contrast dose used in interventional procedures was less than 250ml in each patient. The preoperative and 24 h -postoperative serum creatinine (sCr), serum cystatin C (Cys C) levels were determined, and based on the modification of dietary renal disease (MDRD) equation and Larsson equation the estimated glomerular filtration rates (eGFR) were separately calculated. Results Compared with preoperative values, the 24 h - postoperative mean sCr and Cys C levels were increased significantly (P=0. 001, P=0. 015 respectively), while the average eGFR rates were remarkably decreased (P< 0. 000 1 by using MDRD equation, and P=0. 021 by using Larsson equation). No kidney damage that needed to be treated occurred in all patients. Conclusion The contrast dose used in neuro - interventional procedures can cause decline of renal function in patients with type 2 diabetes mellitus. The combined determination of sCr and Cys C levels is helpful for the detection of contrast - induced changes in renal function as early as possible. The use of conventional dose of contrast agent in neuro - interventional procedures is safe for patients with type 2 diabetes mellitus. (J Intervent Radiol, 2018, 27:277-280)
3.Effect of calorie-restricted diet combined with intestinal microecological preparation on clinical outcomes in overweight/obese infertile patients
Ying ZHONG ; Hong LUO ; Shubiao HAN ; Feng ZHOU ; Qi SONG ; Tianping LI ; Hailan SUN
Chinese Journal of Clinical Nutrition 2023;31(6):336-342
Objective:To investigate the effects of calorie-restricted diet (CRD) combined with intestinal microecological preparation on the clinical outcomes in overweight/obese infertile patients undergoing frozen-thawed embryo transfer (FET) cycle.Methods:252 overweight/obese infertile patients who met the inclusion and exclusion criteria were included and divided into overweight intervention group, overweight control group, obese intervention group and obese control group, according to body mass index (BMI) and whether or not they received nutritional intervention. Clinical outcome indexes and changes in anthropometry and body composition before and after intervention were compared across all groups.Results:Body mass, BMI, body fat percentage, waist-to-hip ratio and visceral fat grade were significantly decreased after nutritional intervention in both overweight and obese intervention groups (both P<0.001). Among overweight patients, follicle count [(17.89±4.97) vs. (16.22±5.41), P=0.027], live births [(0.64±4.77) vs. (0.36±8.61), P=0.005] and the rate of live birth (47.19% vs. 30.19%, P=0.005) were significantly increased in the intervention group compared with the control group. Among obese patients, live births [(0.89±3.79) vs. (0.48±3.69), P=0.040] and the rate of live birth (64.29% vs. 37.93%, P=0.047) were significantly increased in the intervention group. Conclusion:In overweight and obese infertile patients undergoing FET cycle, the nutritional intervention of CRD combined with complex intestinal microecological preparation can help reduce weight and body fat, and may be beneficial to improving the success rate of assisted reproductive technology.
4. Research progress of linezolid-induced lactic acidosis
Naiju ZHANG ; Lingti KONG ; Tianping CHEN ; Rui HUANG ; Zhong CHEN ; Fan ZHANG ; Juan XIA ; Jinchun LIU
Chinese Journal of Clinical Pharmacology and Therapeutics 2020;25(12):1408-1413
Linezolid is an oxazolidinone antibacterial agent used in infections caused by gram-positive cocci such as methicillin-resistant staphylococcus aureus, penicillin-resistant pneumococcus and vancomycin-resistant enterococcus. Lactic acidosis is one of the adverse reactions of linezolid. The risk factors of lactic acidosis caused by linezolid are long-term exposure, liver dysfunction, renal dysfunction, mitochondrial DNA A2706G polymorphism, combined use of drugs affecting mitochondrial function, etc. The symptoms of lactic acidosis caused by linezolid are nausea, vomiting, drowsiness, shortness of breath, tachycardia, and hypotension, etc., which can be identified early by close monitoring of laboratory indicators such as blood lactic acid, pH, and blood drug concentration. The mechanism of lactic acidosis induced by linezolid may be related to mitochondrial toxicity. The lactic acidosis of linezolid can be caused by reducing drug dose, stopping drug or even in vitro renal replacement therapy, and strengthening symptomatic support therapy if necessary. This review is intended to provide ideas for the clinical prevention and treatment of lactate acidosis caused by linezolid.